Dicer is an RNaseIII-like enzyme capable of cleaving double-stranded RNA (dsRNA) into smaller 21-23 nt RNA fragments known as short interfering RNA (siRNAs). It targets the selective degradation of complementary RNAs in a posttranscriptional gene silencing (PTGS) manner and is key for cell differentiation and development. Unlike long-dsRNA-dependent PTGS which is limited to certain cell types, siRNA can act in a wide variety of cells. Mutations in Dicer are found in blastoma, breast cancer, adenocarcinoma, and pancreatitis. Dicer also appears to be involved in myelination and nervous system protection, as well as miRNA-induced pathologies found in vision and hearing sensory cells and cardiovascular diseases. The Dicer antibody allowed Doi’s group to determine that Dicer and eIF2 family transcription factors mediate PTGS synergistically...


